stomach pain after eating on tirzepatide Dosing Day 1 of taking tirzepatide

Key Stakeholders 2

Not everyone responds

This medication was FDA-approved for weight loss in 2023, and studies have shown that participants lost an average of 35.5 pounds after 72 weeks of taking the medication at its lowest dose, with the average amount of weight loss getting higher as the dosage increases

Sources Mehrtash, F., Dushay, J., & Manson, J

Additional safety considerations include: Acute pancreatitis risk : Patients should be monitored for severe abdominal pain Gallbladder disease : Including cholelithiasis and cholecystitis Dehydration and acute kidney injury : Particularly with gastrointestinal side effects Hypoglycemia : When used with insulin or sulfonylureas in patients with diabetes Diabetic retinopathy complications : Particularly with semaglutide in patients with pre-existing retinopathy Patients with hypothyroidism should undergo thyroid function monitoring when starting weight loss injections

Understanding the complete list of injectable peptides helps you see the full scope of compounds that use this same approach